211 related articles for article (PubMed ID: 19643942)
1. Systemic inflammatory markers in COPD: results from the Bergen COPD Cohort Study.
Eagan TM; Ueland T; Wagner PD; Hardie JA; Mollnes TE; Damås JK; Aukrust P; Bakke PS
Eur Respir J; 2010 Mar; 35(3):540-8. PubMed ID: 19643942
[TBL] [Abstract][Full Text] [Related]
2. Body composition and plasma levels of inflammatory biomarkers in COPD.
Eagan TM; Aukrust P; Ueland T; Hardie JA; Johannessen A; Mollnes TE; Damås JK; Bakke PS; Wagner PD
Eur Respir J; 2010 Nov; 36(5):1027-33. PubMed ID: 20413541
[TBL] [Abstract][Full Text] [Related]
3. The value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease.
Karadag F; Kirdar S; Karul AB; Ceylan E
Eur J Intern Med; 2008 Mar; 19(2):104-8. PubMed ID: 18249305
[TBL] [Abstract][Full Text] [Related]
4. Circulating vascular endothelial growth factor and systemic inflammatory markers in patients with stable and exacerbated chronic obstructive pulmonary disease.
Valipour A; Schreder M; Wolzt M; Saliba S; Kapiotis S; Eickhoff P; Burghuber OC
Clin Sci (Lond); 2008 Oct; 115(7):225-32. PubMed ID: 18307413
[TBL] [Abstract][Full Text] [Related]
5. [Systemic inflammation among stable ex smokers with chronic obstructive pulmonary disease].
Morales S A; Dreyse D J; Díaz P O; Saldías P F; Carrasco M; Lisboa B C
Rev Med Chil; 2010 Aug; 138(8):957-64. PubMed ID: 21140052
[TBL] [Abstract][Full Text] [Related]
6. Dynamic pulmonary hyperinflation and low grade systemic inflammation in stable COPD patients.
Gatta D; Aliprandi G; Pini L; Zanardini A; Fredi M; Tantucci C
Eur Rev Med Pharmacol Sci; 2011 Sep; 15(9):1068-73. PubMed ID: 22013730
[TBL] [Abstract][Full Text] [Related]
7. [C-Reactive protein levels in patients with chronic obstructive pulmonary disease].
Díaz O; Parada A; Ramos C; Klaassen J; Díaz JC; Andresen M; Lisboa C; Saldías F
Rev Med Chil; 2012 May; 140(5):569-78. PubMed ID: 23096661
[TBL] [Abstract][Full Text] [Related]
8. Circulating visfatin in chronic obstructive pulmonary disease.
Liu X; Ji Y; Chen J; Li S; Luo F
Nutrition; 2009 Apr; 25(4):373-8. PubMed ID: 19056239
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal follow-up of systemic inflammation after acute exacerbations of COPD.
Groenewegen KH; Dentener MA; Wouters EF
Respir Med; 2007 Nov; 101(11):2409-15. PubMed ID: 17644367
[TBL] [Abstract][Full Text] [Related]
10. [Correlation among the levels of C-reactive protein and interleukin-18, quality of life, and lung function in patients with chronic obstructive pulmonary disease].
Long H; Luo H; Chen P; Li Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Nov; 36(11):1090-6. PubMed ID: 22169727
[TBL] [Abstract][Full Text] [Related]
11. Plasma leptin and adiponectin in COPD exacerbations: associations with inflammatory biomarkers.
Krommidas G; Kostikas K; Papatheodorou G; Koutsokera A; Gourgoulianis KI; Roussos C; Koulouris NG; Loukides S
Respir Med; 2010 Jan; 104(1):40-6. PubMed ID: 19782551
[TBL] [Abstract][Full Text] [Related]
12. Identification of patients with chronic obstructive pulmonary disease (COPD) by measurement of plasma biomarkers.
Shaker SB; von Wachenfeldt KA; Larsson S; Mile I; Persdotter S; Dahlbäck M; Broberg P; Stoel B; Bach KS; Hestad M; Fehniger TE; Dirksen A
Clin Respir J; 2008 Jan; 2(1):17-25. PubMed ID: 20298300
[TBL] [Abstract][Full Text] [Related]
13. [Etiology and biomarkers of systemic inflammation in mild to moderate COPD exacerbations].
Saldías PF; Díaz PO; Dreyse DJ; Gaggero BA; Sandoval AC; Lisboa BC
Rev Med Chil; 2012 Jan; 140(1):10-8. PubMed ID: 22552550
[TBL] [Abstract][Full Text] [Related]
14. [The influence of inflammatory process on the ventilatory impairment in patients with stable chronic obstructive pulmonary disease].
Komnata K
Pneumonol Alergol Pol; 2010; 78(4):271-8. PubMed ID: 20665447
[TBL] [Abstract][Full Text] [Related]
15. Inflammatory biomarkers and comorbidities in chronic obstructive pulmonary disease.
Thomsen M; Dahl M; Lange P; Vestbo J; Nordestgaard BG
Am J Respir Crit Care Med; 2012 Nov; 186(10):982-8. PubMed ID: 22983959
[TBL] [Abstract][Full Text] [Related]
16. C-reactive protein levels and clinically important predictive outcomes in stable COPD patients.
de Torres JP; Cordoba-Lanus E; López-Aguilar C; Muros de Fuentes M; Montejo de Garcini A; Aguirre-Jaime A; Celli BR; Casanova C
Eur Respir J; 2006 May; 27(5):902-7. PubMed ID: 16455829
[TBL] [Abstract][Full Text] [Related]
17. Levels of inflammatory mediators in chronic obstructive pulmonary disease patients with anemia of chronic disease: a case-control study.
Boutou AK; Pitsiou GG; Stanopoulos I; Kontakiotis T; Kyriazis G; Argyropoulou P
QJM; 2012 Jul; 105(7):657-63. PubMed ID: 22355163
[TBL] [Abstract][Full Text] [Related]
18. Systemic inflammation and metabolic syndrome in stable COPD patients.
Akpınar EE; Akpınar S; Ertek S; Sayın E; Gülhan M
Tuberk Toraks; 2012; 60(3):230-7. PubMed ID: 23030748
[TBL] [Abstract][Full Text] [Related]
19. C-reactive protein in patients with COPD, control smokers and non-smokers.
Pinto-Plata VM; Müllerova H; Toso JF; Feudjo-Tepie M; Soriano JB; Vessey RS; Celli BR
Thorax; 2006 Jan; 61(1):23-8. PubMed ID: 16143583
[TBL] [Abstract][Full Text] [Related]
20. Associations between BODE index and systemic inflammatory biomarkers in COPD.
Gaki E; Kontogianni K; Papaioannou AI; Bakakos P; Gourgoulianis KI; Kostikas K; Alchanatis M; Papiris S; Loukides S
COPD; 2011 Dec; 8(6):408-13. PubMed ID: 22149400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
